BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 23092848)

  • 1. DNA sequence analyses of blended herbal products including synthetic cannabinoids as designer drugs.
    Ogata J; Uchiyama N; Kikura-Hanajiri R; Goda Y
    Forensic Sci Int; 2013 Apr; 227(1-3):33-41. PubMed ID: 23092848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds.
    Dresen S; Ferreirós N; Pütz M; Westphal F; Zimmermann R; Auwärter V
    J Mass Spectrom; 2010 Oct; 45(10):1186-94. PubMed ID: 20857386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of detection frequency and type of synthetic cannabinoids in herbal compounds analyzed by Istanbul Narcotic Department of the Council of Forensic Medicine, Turkey.
    Gurdal F; Asirdizer M; Aker RG; Korkut S; Gocer Y; Kucukibrahimoglu EE; Ince CH
    J Forensic Leg Med; 2013 Aug; 20(6):667-72. PubMed ID: 23910858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Spice in France: mixed herbs containing synthetic cannabinoids].
    Schlatter J; Chiadmi F; Chariot P
    Ann Biol Clin (Paris); 2012; 70(4):413-22. PubMed ID: 22796613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs?
    Auwärter V; Dresen S; Weinmann W; Müller M; Pütz M; Ferreirós N
    J Mass Spectrom; 2009 May; 44(5):832-7. PubMed ID: 19189348
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemical analysis of synthetic cannabinoids as designer drugs in herbal products.
    Uchiyama N; Kikura-Hanajiri R; Ogata J; Goda Y
    Forensic Sci Int; 2010 May; 198(1-3):31-8. PubMed ID: 20117892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smart drugs: green shuttle or real drug?
    Cornara L; Borghesi B; Canali C; Andrenacci M; Basso M; Federici S; Labra M
    Int J Legal Med; 2013 Nov; 127(6):1109-23. PubMed ID: 23842669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Spice drugs: cannabinoids as a new designer drugs].
    Mustata C; Torrens M; Pardo R; Pérez C; ; Farré M
    Adicciones; 2009; 21(3):181-6. PubMed ID: 19718488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct analysis in real time mass spectrometry with collision-induced dissociation for structural analysis of synthetic cannabinoids.
    Musah RA; Domin MA; Cody RB; Lesiak AD; Dane AJ; Shepard JR
    Rapid Commun Mass Spectrom; 2012 Oct; 26(19):2335-42. PubMed ID: 22956326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quadrupole-time-of-flight mass spectrometry screening for synthetic cannabinoids in herbal blends.
    Ibáñez M; Bijlsma L; van Nuijs AL; Sancho JV; Haro G; Covaci A; Hernández F
    J Mass Spectrom; 2013 Jun; 48(6):685-94. PubMed ID: 23722959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly sensitive screening and analytical characterization of synthetic cannabinoids in nine different herbal mixtures.
    Alves VL; Gonçalves JL; Aguiar J; Caldeira MJ; Teixeira HM; Câmara JS
    Anal Bioanal Chem; 2021 Mar; 413(8):2257-2273. PubMed ID: 33575815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid identification of synthetic cannabinoids in herbal samples via direct analysis in real time mass spectrometry.
    Musah RA; Domin MA; Walling MA; Shepard JR
    Rapid Commun Mass Spectrom; 2012 May; 26(9):1109-14. PubMed ID: 22467461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of SPME-HS-GC-MS for the analysis of herbal products containing synthetic cannabinoids.
    Cox AO; Daw RC; Mason MD; Grabenauer M; Pande PG; Davis KH; Wiley JL; Stout PR; Thomas BF; Huffman JW
    J Anal Toxicol; 2012 Jun; 36(5):293-302. PubMed ID: 22582264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
    Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
    Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and structural characterization of the synthetic cannabinoid 3-(1-adamantoyl)-1-pentylindole as an additive in 'herbal incense'.
    Kneisel S; Westphal F; Bisel P; Brecht V; Broecker S; Auwärter V
    J Mass Spectrom; 2012 Feb; 47(2):195-200. PubMed ID: 22359329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel third-generation synthetic cannabinoids in products by ultra-performance liquid chromatography and time-of-flight mass spectrometry.
    Shanks KG; Behonick GS; Dahn T; Terrell A
    J Anal Toxicol; 2013 Oct; 37(8):517-25. PubMed ID: 23946450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Eight Synthetic Cannabinoids, Including 5F-AKB48 in Seized Herbal Products Using DART-TOF-MS and LC-QTOF-MS as Nontargeted Screening Methods.
    Moore KN; Garvin D; Thomas BF; Grabenauer M
    J Forensic Sci; 2017 Sep; 62(5):1151-1158. PubMed ID: 28597943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A fast and inexpensive procedure for the isolation of synthetic cannabinoids from 'Spice' products using a flash chromatography system.
    Moosmann B; Kneisel S; Wohlfarth A; Brecht V; Auwärter V
    Anal Bioanal Chem; 2013 May; 405(12):3929-35. PubMed ID: 23064708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Discrimination of Kratom Products by an Improved PCR-RFLP Method].
    Ogata J; Kawamura M; Hakamatsuka T; Kikura-Hanajiri R
    Yakugaku Zasshi; 2020; 140(12):1501-1508. PubMed ID: 33268690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect and occurrence of synthetic cannabinoids].
    Tuv SS; Strand MC; Karinen R; Øiestad EL; Christophersen AS; Vindenes V
    Tidsskr Nor Laegeforen; 2012 Oct; 132(20):2285-8. PubMed ID: 23736196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.